Health : Medical Research (Grantmaking)

Cancer Research Institute

The Leader in Immunotherapy

four stars

94.69

29 Broadway, Floor 4 New York, NY 10006
tel: (800) 992-2623   Web Site
EIN: 13-1837442

Board Leadership
Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO
Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs

  Score
(out of 100)
Rating
Overall Score & Rating 94.69 four stars
  Financial 92.50 four stars
  Accountability & Transparency 100.00 four stars
This rating was published 06/01/2017 and includes data from FY2016, the most recent 990 received at that time.

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Results Information

Charting Impact

What is your organization aiming to accomplish?

What are your strategies for making this happen?

What are your organization's capabilities for doing this?

How will your organization know if you are making progress?

What have and haven't you accomplished so far?

Did you find the Results Information useful?
There was a problem saving your response. Please try again.
Thank you for your feedback. If you wish to share more about this data you may do so below.
Your feedback has been recorded
There was a problem saving your response. Please try again.
This results data is current as of November 2017, when it was provided to us by GuideStar. Results information published on this organization's rating page has no effect on its rating at this time. data iconLearn More

Financial

four stars

92.50

Accountability & Transparency

four stars

100.00

This rating was published 06/01/2017 and includes data from FY2016, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
86.3%
  Administrative Expenses 4.4%
  Fundraising Expenses 9.1%
  Fundraising Efficiency $0.08
  Working Capital Ratio (years) 1.57
  Program Expenses Growth 20.3%
  Liabilities to Assets 51.5%
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
Joint Cost Allocation Adjustment applied. Learn more.
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $38,228,694
   Federated Campaigns $682,955
   Membership Dues $0
   Fundraising Events $2,664,397
   Related Organizations $0
   Government Grants $0
Total Contributions $41,576,046
   Program Service Revenue $0
Total Primary Revenue $41,576,046
   Other Revenue $3,434,528
TOTAL REVENUE $45,010,574
   
EXPENSES (Adjusted)  
   Program Expenses $26,896,086
   Administrative Expenses $1,430,166
   Fundraising Expenses $2,870,197
TOTAL FUNCTIONAL EXPENSES $31,196,449
   
Payments to Affiliates $0
Excess (or Deficit) for the year $13,814,125
   
Net Assets $53,653,098

Charts

Compensation % of Expenses Paid to Title
$399,188 1.27% Jill O'Donnell-Tormey Chief Executive Officer

Mission

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Highly Rated

Charity Name & State Overall Score Overall Rating
Cancer Research Institute (NY) 94.69 four stars
Israel Cancer Association USA (FL) 89.80 three stars
Mesothelioma Applied Research Foundation (VA) 90.88 four stars
Chordoma Foundation (NC) 91.57 four stars
The THANC Foundation (NY) 89.10 three stars

Compare These Charities (Highly Rated)

Charity Contact Info

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006
tel: (800) 992-2623
fax: (212) 832-9376
EIN: 13-1837442

Visit Web Site

Board Leadership

Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO

Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs